Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease

Virology. 2002 Jan 5;292(1):137-49. doi: 10.1006/viro.2001.1184.

Abstract

Human immunodeficiency virus type 1 (HIV-1) protease activity is targeted at nine cleavage sites comprising different amino acid sequences in the viral Gag-Pol polyprotein. Amino acid polymorphisms in protease and in regions of Gag, particularly p7(NC) and the C-cleavage site between p2 and p7(NC), occur in natural variants of HIV-1 within infected patients. Studies were designed to examine the role of natural polymorphisms in protease and to identify determinants in Gag that modulate protease processing activity. Closely related Gag-Pol regions from an HIV-1-infected mother and two children were evaluated for processing in an inducible expression system, for protease activity on cleavage-site analogues, and for impact on replication by recombinant viruses. Gag-Pol regions displayed one of three processing phenotypes based on the appearance of Gag intermediates and accumulation of mature p24(CA). Gag-Pol regions that were processed rapidly to produce p24(CA) resulted in high-level replication by recombinant viruses, while slow-processing Gag-Pol variants resulted in recombinant viruses that replicated with reduced kinetics in both T cell lines and peripheral blood mononuclear cells. Direct impact by Gag sequences on processing by protease was assessed by construction of chimeric Gag-Pol regions and by site-directed mutagenesis. Optimal protease activity occurred when Gag and Pol regions were derived from the same gag-pol allele. Heterologous Gag regions generally diminished rates and extent of protease processing. Natural polymorphisms in novel positions in p7(NC) and the C-cleavage site have a dominant effect on protease processing activity. Accumulation of Gag products after processing at the C site appears to delay subsequent cleavage and production of mature p24(CA).

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alleles
  • Amino Acid Sequence*
  • Capsid / genetics*
  • Capsid / metabolism
  • Capsid Proteins*
  • Fusion Proteins, gag-pol / genetics
  • Fusion Proteins, gag-pol / metabolism*
  • Gene Products, gag / genetics*
  • Gene Products, gag / metabolism
  • HIV Infections / virology
  • HIV Protease / metabolism*
  • HIV-1 / genetics
  • HIV-1 / metabolism
  • HIV-1 / physiology
  • Humans
  • Jurkat Cells
  • Molecular Sequence Data
  • Phenotype
  • Polymorphism, Genetic*
  • Viral Proteins*
  • Virus Replication
  • gag Gene Products, Human Immunodeficiency Virus

Substances

  • Capsid Proteins
  • Fusion Proteins, gag-pol
  • Gene Products, gag
  • NCP7 protein, Human immunodeficiency virus 1
  • Viral Proteins
  • gag Gene Products, Human Immunodeficiency Virus
  • HIV Protease